Detalhe da pesquisa
1.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37302395
2.
4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 22(3): 332-340, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539729
3.
Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.
Lancet Oncol
; 18(7): 929-945, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600210
4.
2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial.
Lancet
; 382(9897): 1021-8, 2013 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23871490
5.
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial.
Lancet Oncol
; 14(10): 989-98, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23902874
6.
Ten-year audit of melanoma in a central England population.
Acta Derm Venereol
; 91(4): 440-3, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21336477
7.
When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management.
Am Soc Clin Oncol Educ Book
; 41: 1-11, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33956493
8.
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
N Engl J Med
; 355(18): 1851-62, 2006 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-17079759
9.
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
Radiother Oncol
; 120(1): 114-8, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27046390
10.
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
Radiother Oncol
; 100(1): 93-100, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21752481